vs
NOVAVAX INC（NVAX）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是NOVAVAX INC的1.5倍（$225.0M vs $147.3M），NOVAVAX INC同比增速更快（66.8% vs 24.9%），GIBRALTAR INDUSTRIES, INC.自由现金流更多（$26.2M vs $-41.6M），过去两年NOVAVAX INC的营收复合增速更高（25.3% vs -12.3%）
诺瓦瓦克斯是一家总部位于美国马里兰州盖瑟斯堡的生物科技企业，专注于传染病疫苗研发。其开发的新冠疫苗现由赛诺菲负责商业化，同时还在布局流感、呼吸道合胞病毒（RSV）、禽流感、带状疱疹、艰难梭菌感染、疟疾等多个领域的疫苗管线。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
NVAX vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.5倍
$147.3M
营收增速更快
NVAX
高出41.9%
24.9%
自由现金流更多
ROCK
多$67.8M
$-41.6M
两年增速更快
NVAX
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $147.3M | $225.0M |
| 净利润 | $17.5M | — |
| 毛利率 | 85.0% | 25.3% |
| 营业利润率 | 9.7% | 7.9% |
| 净利率 | 11.9% | — |
| 营收同比 | 66.8% | 24.9% |
| 净利润同比 | 121.6% | — |
| 每股收益（稀释后） | $0.28 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVAXROCK
| Q4 25 | $147.3M | $225.0M | ||
| Q3 25 | $70.4M | $310.9M | ||
| Q2 25 | $239.2M | $309.5M | ||
| Q1 25 | $666.5M | $290.0M | ||
| Q4 24 | $88.3M | $180.1M | ||
| Q3 24 | $84.5M | $277.1M | ||
| Q2 24 | $415.5M | $273.6M | ||
| Q1 24 | $93.9M | $292.5M |
净利润NVAXROCK
| Q4 25 | $17.5M | — | ||
| Q3 25 | $-202.4M | $-89.1M | ||
| Q2 25 | $106.5M | $26.0M | ||
| Q1 25 | $518.6M | $21.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-121.3M | $34.0M | ||
| Q2 24 | $162.4M | $32.2M | ||
| Q1 24 | $-147.6M | $24.9M |
毛利率NVAXROCK
| Q4 25 | 85.0% | 25.3% | ||
| Q3 25 | 69.5% | 26.6% | ||
| Q2 25 | 93.6% | 28.4% | ||
| Q1 25 | 97.9% | 26.8% | ||
| Q4 24 | 58.5% | 29.0% | ||
| Q3 24 | 28.3% | 29.4% | ||
| Q2 24 | 88.9% | 30.5% | ||
| Q1 24 | 36.9% | 28.9% |
营业利润率NVAXROCK
| Q4 25 | 9.7% | 7.9% | ||
| Q3 25 | -252.7% | 12.8% | ||
| Q2 25 | 42.2% | 12.8% | ||
| Q1 25 | 77.4% | 8.8% | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | -158.6% | 15.6% | ||
| Q2 24 | 38.7% | 14.9% | ||
| Q1 24 | -154.3% | 10.8% |
净利率NVAXROCK
| Q4 25 | 11.9% | — | ||
| Q3 25 | -287.3% | -28.6% | ||
| Q2 25 | 44.5% | 8.4% | ||
| Q1 25 | 77.8% | 7.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -143.5% | 12.3% | ||
| Q2 24 | 39.1% | 11.8% | ||
| Q1 24 | -157.2% | 8.5% |
每股收益（稀释后）NVAXROCK
| Q4 25 | $0.28 | — | ||
| Q3 25 | $-1.25 | $-2.98 | ||
| Q2 25 | $0.62 | $0.87 | ||
| Q1 25 | $2.93 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.76 | $1.11 | ||
| Q2 24 | $0.99 | $1.05 | ||
| Q1 24 | $-1.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $735.1M | $115.7M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $-127.8M | $950.4M |
| 总资产 | $1.2B | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资NVAXROCK
| Q4 25 | $735.1M | $115.7M | ||
| Q3 25 | $762.9M | $89.4M | ||
| Q2 25 | $612.3M | $43.3M | ||
| Q1 25 | $731.5M | $25.1M | ||
| Q4 24 | $923.1M | $269.5M | ||
| Q3 24 | $909.5M | $228.9M | ||
| Q2 24 | $1.0B | $179.1M | ||
| Q1 24 | $480.6M | $146.7M |
总债务NVAXROCK
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益NVAXROCK
| Q4 25 | $-127.8M | $950.4M | ||
| Q3 25 | $-156.7M | $951.8M | ||
| Q2 25 | $37.6M | $1.0B | ||
| Q1 25 | $-75.6M | $1.0B | ||
| Q4 24 | $-623.8M | $1.0B | ||
| Q3 24 | $-526.4M | $1.0B | ||
| Q2 24 | $-431.7M | $975.7M | ||
| Q1 24 | $-867.1M | $940.2M |
总资产NVAXROCK
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.3B | $1.5B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.7B | $1.4B | ||
| Q2 24 | $1.8B | $1.4B | ||
| Q1 24 | $1.4B | $1.3B |
负债/权益比NVAXROCK
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-39.5M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $-41.6M | $26.2M |
| 自由现金流率自由现金流/营收 | -28.2% | 11.7% |
| 资本支出强度资本支出/营收 | 1.4% | 4.1% |
| 现金转化率经营现金流/净利润 | -2.25× | — |
| 过去12个月自由现金流最近4个季度 | $-250.2M | $120.6M |
8季度趋势，按日历期对齐
经营现金流NVAXROCK
| Q4 25 | $-39.5M | $35.5M | ||
| Q3 25 | $107.8M | $73.0M | ||
| Q2 25 | $-127.5M | $44.9M | ||
| Q1 25 | $-185.5M | $13.7M | ||
| Q4 24 | $-87.3M | $19.9M | ||
| Q3 24 | $-144.8M | $64.7M | ||
| Q2 24 | $314.3M | $36.5M | ||
| Q1 24 | $-83.6M | $53.2M |
自由现金流NVAXROCK
| Q4 25 | $-41.6M | $26.2M | ||
| Q3 25 | $105.8M | $64.8M | ||
| Q2 25 | $-127.7M | $27.3M | ||
| Q1 25 | $-186.7M | $2.3M | ||
| Q4 24 | $-100.3M | $14.1M | ||
| Q3 24 | $-146.2M | $60.5M | ||
| Q2 24 | $311.4M | $33.5M | ||
| Q1 24 | $-90.4M | $48.8M |
自由现金流率NVAXROCK
| Q4 25 | -28.2% | 11.7% | ||
| Q3 25 | 150.2% | 20.8% | ||
| Q2 25 | -53.4% | 8.8% | ||
| Q1 25 | -28.0% | 0.8% | ||
| Q4 24 | -113.6% | 7.8% | ||
| Q3 24 | -173.0% | 21.8% | ||
| Q2 24 | 74.9% | 12.2% | ||
| Q1 24 | -96.4% | 16.7% |
资本支出强度NVAXROCK
| Q4 25 | 1.4% | 4.1% | ||
| Q3 25 | 2.9% | 2.6% | ||
| Q2 25 | 0.1% | 5.7% | ||
| Q1 25 | 0.2% | 3.9% | ||
| Q4 24 | 14.8% | 3.3% | ||
| Q3 24 | 1.6% | 1.5% | ||
| Q2 24 | 0.7% | 1.1% | ||
| Q1 24 | 7.3% | 1.5% |
现金转化率NVAXROCK
| Q4 25 | -2.25× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.20× | 1.73× | ||
| Q1 25 | -0.36× | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | 1.94× | 1.13× | ||
| Q1 24 | — | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVAX
| Licensing Royalties And Other | $107.9M | 73% |
| Products | $39.2M | 27% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
